Table 1.

Comparison of BRAF V600E mutation status and clinicopathological features of 128 patients with PTC.

Variables	No. of patients	BRAF mutation		P value
		Positive	Negative
Age, year
<45	82	42	40	0.025
≥45	46	33	13
Gender
Male	25	17	8	0.25
Female	103	58	47
Clinical stage
I	68	38	30	0.26
II	8	3	5
III	8	5	3
IV	38	26	12
NA	6	3	3
I+ III	76	41	35	0.14
III+IV	46	31	15
Lymphovascular Invasion
No	7	2	5	0.059
Yes	121	73	48
Metastasis
No	117	69	48	0.76
Yes	11	6	5